Noriko Ishigami

1.2k total citations
13 papers, 976 citations indexed

About

Noriko Ishigami is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Noriko Ishigami has authored 13 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 6 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Noriko Ishigami's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Alzheimer's disease research and treatments (2 papers). Noriko Ishigami is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Alzheimer's disease research and treatments (2 papers). Noriko Ishigami collaborates with scholars based in Japan, United Kingdom and Germany. Noriko Ishigami's co-authors include Takahiko Tokuda, Takashi Kasai, Masanori Nakagawa, Omar M. A. El‐Agnaf, David Allsop, Safa Shehab, Sheeja Varghese, Mustafa T. Ardah, M.M. Qureshi and Akira Tamaoka and has published in prestigious journals such as Neurology, Brain Research and The FASEB Journal.

In The Last Decade

Noriko Ishigami

13 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noriko Ishigami Japan 11 542 448 243 211 189 13 976
Masakuni Amari Japan 15 431 0.8× 503 1.1× 275 1.1× 123 0.6× 207 1.1× 45 1.0k
Adele Woodhouse Australia 18 288 0.5× 334 0.7× 341 1.4× 360 1.7× 139 0.7× 32 990
Pol Andrés‐Benito Spain 22 345 0.6× 520 1.2× 467 1.9× 271 1.3× 313 1.7× 62 1.2k
Dengshun Wang United States 12 728 1.3× 544 1.2× 269 1.1× 427 2.0× 260 1.4× 21 1.2k
Matthias Höllerhage Germany 21 574 1.1× 440 1.0× 559 2.3× 331 1.6× 233 1.2× 42 1.4k
Michael W. DeLucia United States 11 456 0.8× 882 2.0× 340 1.4× 207 1.0× 296 1.6× 11 1.2k
Lakshman Puli Finland 11 176 0.3× 422 0.9× 238 1.0× 268 1.3× 202 1.1× 14 883
S. S. Jossan Sweden 17 276 0.5× 215 0.5× 255 1.0× 347 1.6× 143 0.8× 26 820
Sakura Minami United States 17 229 0.4× 850 1.9× 472 1.9× 322 1.5× 419 2.2× 37 1.5k
M. Hutton United States 10 426 0.8× 1.1k 2.4× 546 2.2× 238 1.1× 222 1.2× 16 1.4k

Countries citing papers authored by Noriko Ishigami

Since Specialization
Citations

This map shows the geographic impact of Noriko Ishigami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Ishigami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Ishigami more than expected).

Fields of papers citing papers by Noriko Ishigami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Ishigami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Ishigami. The network helps show where Noriko Ishigami may publish in the future.

Co-authorship network of co-authors of Noriko Ishigami

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Ishigami. A scholar is included among the top collaborators of Noriko Ishigami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Ishigami. Noriko Ishigami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kasai, Takashi, Takahiko Tokuda, Ryotaro Ishii, et al.. (2014). Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. Journal of Neurology. 261(6). 1203–1209. 31 indexed citations
2.
Ishigami, Noriko, Takahiko Tokuda, Masaya Ikegawa, et al.. (2012). Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy. Movement Disorders. 27(7). 851–857. 25 indexed citations
3.
Tokuda, Takahiko, et al.. (2011). Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome. Neuroscience Letters. 494(1). 86–88. 16 indexed citations
4.
Tokuda, Takahiko, M.M. Qureshi, Mustafa T. Ardah, et al.. (2010). Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology. 75(20). 1766–1770. 409 indexed citations
5.
Tokuda, Takahiko, Hiroaki Fukumoto, Takashi Kasai, et al.. (2010). P3‐210: High‐molecular weight β‐amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. Alzheimer s & Dementia. 6(4S_Part_17). 2 indexed citations
6.
Fukumoto, Hiroaki, Takahiko Tokuda, Takashi Kasai, et al.. (2010). High‐molecular‐weight β‐amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. The FASEB Journal. 24(8). 2716–2726. 209 indexed citations
7.
Mizuno, Toshiki, Masaki Kondo, Noriko Ishigami, et al.. (2009). Cognitive Impairment and Cerebral Hypoperfusion in a CADASIL Patient Improved During Administration of Lomerizine. Clinical Neuropharmacology. 32(2). 113–116. 12 indexed citations
8.
Ohnishi, Masato, Michiaki Fukui, Takeshi Ishikawa, et al.. (2008). Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. Metabolism. 57(12). 1760–1764. 24 indexed citations
9.
Kasai, Takashi, Takahiko Tokuda, Noriko Ishigami, et al.. (2008). Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathologica. 117(1). 55–62. 157 indexed citations
10.
Ishigami, Noriko, et al.. (2008). A case of Charcot-Marie-Tooth disease type 1A with increased cerebrospinal fluid proteins and nerve root hypertrophy. Rinsho Shinkeigaku. 48(6). 419–421. 8 indexed citations
11.
Egashira, Nobuaki, Noriko Ishigami, Kenichi Mishima, et al.. (2007). Δ9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(2). 499–506. 13 indexed citations
12.
Egashira, Nobuaki, Noriko Ishigami, Fengling Pu, et al.. (2007). Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. Phytotherapy Research. 22(1). 65–68. 35 indexed citations
13.
Egashira, Nobuaki, Akiko Yano, Noriko Ishigami, et al.. (2006). Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: Involvement of 5-HT1A receptors in the dorsal hippocampus in rats. Brain Research. 1069(1). 54–62. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masakuni Amari Breakdown of academic impact, for papers by Adele Woodhouse Breakdown of academic impact, for papers by Pol Andrés‐Benito Breakdown of academic impact, for papers by Dengshun Wang Breakdown of academic impact, for papers by Matthias Höllerhage Breakdown of academic impact, for papers by Michael W. DeLucia Breakdown of academic impact, for papers by Lakshman Puli Breakdown of academic impact, for papers by S. S. Jossan Breakdown of academic impact, for papers by Sakura Minami Breakdown of academic impact, for papers by M. Hutton
Rankless by CCL
2026